| Issue Date | Title | Author(s) |
| 1999-06-10 | Morphology and other prognostic factors of hepatocellular carcinoma | Chedid, A; Ryan, LM; Dayal, Y; Wolf, BC; Falkson, G |
| 2003-03-01 | Function of a genetically modified human liver cell line that stores, processes and secretes insulin | Tuch, BE; Szymanska, B; Yao, M; Tabiin, MT; Gross, DJ; Holman, S; Swann, MA; Humphrey, RKB; Marshall, GM; Simpson, AM |
| 2000-01-01 | Risk of internal cancers from arsenic in drinking water | Morales, KH; Ryan, L; Kuo, TL; Wu, MM; Chen, CJ |
| 1988-01-01 | Prognostic Factors for Survival in Hepatocellular Carcinoma | Falkson, G; Cnaan, A; Schutt, AJ; Ryan, LM; Falkson, HC |
| 1987-01-01 | A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma: An ECOG study | Falkson, G; Ryan, LM; Johnson, LA; Simson, IW; Coetzer, BJ; Carbone, PP; Creech, RH; Schutt, AJ |
| 2022-11-10 | Laminaria japonica Peptides Suppress Liver Cancer by Inducing Apoptosis: Possible Signaling Pathways and Mechanism. | Wu, Y; Li, Y; Guo, W; Liu, J; Lao, W; Hu, P; Lin, Y; Chen, H |
| 2021-04-15 | Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 -/- mouse model. | Behary, J; Raposo, AE; Amorim, NML; Zheng, H; Gong, L; McGovern, E; Chen, J; Liu, K; Beretov, J; Theocharous, C; Jackson, MT; Seet-Lee, J; McCaughan, GW; El-Omar, EM; Zekry, A |
| 2016-10 | Serum thioredoxin reductase is highly increased in mice with hepatocellular carcinoma and its activity is restrained by several mechanisms. | Zhang, L; Cheng, Q; Zhang, L; Wang, Y; Merrill, GF; Ilani, T; Fass, D; Arnér, ESJ; Zhang, J |
| 2001-03-19 | Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon γ-dependent natural killer cell protection from tumor metastasis | Smyth, MJ; Cretney, E; Takeda, K; Wiltrout, RH; Sedger, LM; Kayagaki, N; Yagita, H; Okumura, K |
| 2008-06 | An aqueous extract of Salacia oblonga root, a herb-derived peroxisome proliferator-activated receptor-alpha activator, by oral gavage over 28 days induces gender-dependent hepatic hypertrophy in rats. | Rong, X; Kim, MS; Su, N; Wen, S; Matsuo, Y; Yamahara, J; Murray, M; Li, Y |
